Santander’s Buyback Engine Is Already Priced—But EPS Accretion Could Surprise

The market's reaction to Santander's latest buyback update was a textbook case of an expectation gap. The bank announced it had spent about €1.82 billion on its share repurchase program, completing roughly 36.1% of the approved maximum. Yet the stock, which has been under pressure, showed no rally. In fact, the shares have fallen 11.7% over the last 20 days. This weak response suggests the scale of the buyback was already priced in.

The whisper number for 2026 was set last year. Management had already completed a €1.7 billion buyback charged against 2025 results. With a stated target to distribute at least €10 billion through buybacks over 2025 and 2026, the market had a clear forward view. The current pace of spending-around €1.82 billion for 36% of the €5 billion program-aligns with that prior cycle. The news didn't move the needle because it was expected.

The bottom line is that the buyback itself is not the surprise. The real signal is in the continued execution. By sticking to the plan, management is signaling confidence in its capital position and its ability to meet its long-term shareholder return goals. The market's muted reaction confirms the capital return story is already in the price.

The Capital Return Engine: Total Remuneration and Sustainability

The bank's total remuneration plan provides the crucial context for judging the buyback's signal. For the first half of 2025, Santander charged approximately €3.4 billion in total shareholder returns against its results. This was an 11% increase from the prior year. More importantly, the structure was balanced: about 25% came from cash dividends and another 25% from share buybacks. This deliberate split shows the buyback is not a standalone event but a core, predictable component of the capital return engine.

The market's job is to weigh this routine execution against the potential upside. The primary benefit of a buyback is EPS accretion. By reducing the share count, each remaining share represents a larger slice of the bank's profit. The bank's own materials note that buybacks increase earnings per share. The question is whether the market is underestimating this mechanical boost. With the bank having already spent about €1.82 billion on its current program, the accretion effect is already in motion.

Yet the sustainability of this engine is the flip side. The total remuneration target is ambitious: at least €10 billion via buybacks charged against 2025 and 2026 results. This implies a significant portion of the bank's capital generation is being directed to shareholders. The market must be assessing whether this pace can continue without straining the bank's capital buffer or its ability to fund growth. The bank's confidence is evident in its stated intent to reward shareholders with 10 billion euros in share buy-backs for 2025 and 2026, but the execution must be flawless to maintain that confidence.

The bottom line is that the buyback is a signal of routine, disciplined capital allocation. The market's muted reaction suggests it sees this as expected, not exceptional. The real arbitrage opportunity lies in the gap between the priced-in routine and the actual EPS accretion. If the buyback continues as planned, the market may be underestimating the sustained pressure it puts on the share count. Conversely, any stumble in execution would quickly reset expectations, revealing the risk that the capital return engine is more fragile than it appears.

Valuation and the Expectation Gap: What's Priced In?

The valuation picture tells a story of recent weakness that may be driven by broader concerns, not the capital return plan itself. The stock trades at a 52-week high of €13.24 but is currently around €11. This gap suggests the market is looking past the buyback news to other pressures. Over the last 20 days, shares have fallen 11.7%, a move that likely reflects sector or macro headwinds rather than a change in the bank's capital allocation story.

The key watchpoint is the expectation gap between current price and analyst targets. A recent analyst rating is a Buy with a $14.50 price target. That implies significant upside from current levels, but it also highlights the market's skepticism. The target is set against a backdrop of a PE TTM of 9.8 and a PB of 1.23, which look cheap. The market may be pricing in the full benefit of the €1.82 billion already spent on buybacks, seeing the EPS accretion as already reflected in the low multiple.

The real arbitrage opportunity lies in the remaining authorization. With 36.1% of the €5 billion program completed, there is still about €3.18 billion left to deploy. The market's muted reaction to the initial spending suggests it views this as a continuation of a known plan. However, if execution stays on track, the full €5 billion could provide a sustained boost to earnings per share that the current valuation may not fully appreciate. The expectation gap is not in the plan, but in the timing and certainty of its payoff.

Catalysts and Risks: Testing the Thesis

The thesis that the buyback is a signal of confidence hinges on execution. The near-term catalysts will test whether management is merely following a plan or actively reinforcing its capital strength. The first and most direct test is the pace of spending against the remaining authorization. With 36.1% of the €5 billion program completed, about €3.18 billion is left. The market has already priced in the initial €1.82 billion. Any acceleration or deceleration in the coming months will be a clear signal. A steady, predictable pace would confirm the buyback is a routine capital allocation tool. A slowdown, however, could trigger a reset of expectations, suggesting capital generation is under more pressure than assumed.

The engine that funds this buyback is capital generation itself. The market must continuously assess whether Santander's core profitability can support the ambitious total remuneration target. Key metrics to watch are net interest income and cost controls. These directly feed the capital buffer that allows for both dividends and buybacks. The next major catalyst is the Q1 2026 earnings report, scheduled for release in late April. This report will be critical for resetting expectations on two fronts: it will show the bank's current capital generation and provide guidance on its capital return plans. Any update on the path to the €10 billion buyback target will be scrutinized for signs of strain or confidence.

The risk is that the buyback becomes a victim of its own predictability. If capital generation falters, the market's expectation of a smooth capital return could quickly turn negative. The current stock price, down 11.7% over the last 20 days, suggests the market is already looking past the buyback news to broader pressures. The bank's ability to maintain its capital generation trajectory will determine whether the buyback remains a priced-in move or becomes a new source of volatility. The next earnings call will be the first real test of that thesis.